×
For best experience we recommend to activate Javascript in your browser.
Neurexophilin 4 antibody (C-Term)
The Rabbit Polyclonal anti-Neurexophilin 4 antibody has been validated for WB, ELISA and IHC. It is suitable to detect Neurexophilin 4 in samples from Human and Rat.
Quick Overview for Neurexophilin 4 antibody (C-Term) (ABIN3185843)
Target
See all Neurexophilin 4 (NXPH4) Antibodies
Neurexophilin 4 (NXPH4)
Reactivity
All reactivities for Neurexophilin 4 antibodies
Human, Rat
Host
All hosts for Neurexophilin 4 antibodies
Rabbit
Clonality
All clonalities for Neurexophilin 4 antibodies
Polyclonal
Conjugate
All conjugates for Neurexophilin 4 antibodies
This Neurexophilin 4 antibody is un-conjugated
Application
All applications for Neurexophilin 4 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-Neurexophilin 4 Antibody
(hide)
Binding Specificity
All epitopes for Neurexophilin 4 antibodies
C-Term
Specificity
Neurexophilin-4 Polyclonal Antibody detects endogenous levels of Neurexophilin-4 protein.
Characteristics
Rabbit Polyclonal to Neurexophilin-4.
Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Immunogen
Synthesized peptide derived from the C-terminal region of human Neurexophilin-4.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
WB 1:500-1:2000, IHC 1:100-1:300, ELISA 1:40000,
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Avoid repeated freeze/thaw cycles.
Storage
-20 °C
Storage Comment
Store at -20°C.
Target Details for Neurexophilin 4
(hide)
Target
Neurexophilin 4 (NXPH4)
Alternative Name
Neurexophilin-4
Molecular Weight
33 kDa
Gene ID
11247
UniProt
O95158
Recently viewed
(hide)
Chat with us , powered by LiveChat